Today the world's biggest pharmaceutical company offered a peek at what it hopes will be the next big thing. The company already markets the world's best selling drug - Lipitor. It cuts so-called "bad" cholesterol. Pfizer's new drug boosts "good" cholesterol, and it's looking pretty solid in trials. If you put the good and the bad together, what do you get? A combo designed to deal with more than strictly 'medical' concerns. From the Health Desk at WGBH, Marketplace's Helen Palmer reports.

39 days ... How are you coming along with those taxes? May want to take notes on what troubles you. The president's panel on tax reform has hit the road to gather suggestions. They won't be hearing from a noted Princeton economist who died a couple of weeks ago. Commentator Glenn Hubbard says that's a real shame, since his ideas deserve a voice. <br />Glenn Hubbard is former head of the President's Council of Economic Advisors. He's now Dean of Columbia's Business School.

It used to be dismissed as the domain of nerds. Nothing like money to improve a reputation. Just ask the folks at the annual Game Developers' Conference. It got underway in San Francisco today. The global video game industry is now worth upwards of $5 Billion. Any wonder that corporate America is ready to embrace its inner geek? As Marketplace's Jeff Tyler reports, that's show biz.